Lv11
50 积分 2024-05-08 加入
Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
5小时前
待确认
High-Throughput Experimentation Reveals Scope and Limitations of Selective Phosphine Reductants and Enables One-Pot mAb Reduction/Conjugation
1个月前
已完结
The antibody–drug conjugate landscape
4个月前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
5个月前
已完结
Topoisomerase I-Mediated DNA Relaxation as a Tool to Study Intercalation of Small Molecules into Supercoiled DNA
8个月前
已关闭
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
9个月前
已完结
Recent advances in the tumor‐penetrating peptide internalizing RGD for cancer treatment and diagnosis
10个月前
已完结
Structure–Activity Relationship of FL118 Platform Position 7 Versus Position 9-Derived Compounds and Their Mechanism of Action and Antitumor Activity
1年前
已完结
Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors
1年前
已完结
皖公网安备34019202002308
